The SLC6A17 gene helps brain cells package certain amino acids, the small building blocks of protein, so they can support nerve signaling. This gene plays an important role in how nerve cells communicate during brain development. When both copies do not work properly, a rare inherited condition can develop, often with developmental delay, low muscle tone, movement differences, and sometimes seizures. Because the SLC6A17 gene is active mainly in the brain, symptoms usually affect learning, behavior, and motor skills rather than other organs.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes carry the code for proteins, the parts of cells that do much of the work. Others mainly help control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLC6A17Gene function
What if the gene works
The SLC6A17 gene helps brain cells package certain amino acids into small sacs used for signaling. This supports normal communication between nerve cells, especially in areas involved in thinking, movement, and behavior.
Risk
What if the gene does not work
Changes in the SLC6A17 gene are linked to a rare inherited condition causing developmental delay, intellectual disability, speech difficulties, and often tremor or other movement problems. Milder or more severe variants can affect onset and severity.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the SLC6A17 gene, no SLC6A17-specific treatment or management approach is currently established. Care is symptom-based rather than guided by a drug choice linked to the SLC6A17 gene.
Conditions associated with SLC6A17
Gene function
What if the gene works
In the brain, the SLC6A17 gene helps nerve cells handle certain amino acids during everyday signaling. Its protein sits mainly in tiny storage sacs near nerve endings, where messages are prepared for release. Understanding what the SLC6A17 gene does in nerve cells helps explain how brain cells keep communication organized.
The SLC6A17 gene helps move certain amino acids into tiny sacs inside nerve endings. This keeps those building blocks close to where nerve cells prepare chemical messages.
Its protein works in synaptic vesicles (small storage sacs that release signals) rather than mainly on the cell surface. This helps nerve cells organize and store selected amino acids at the release site.
By stocking these small sacs, the SLC6A17 gene supports steady communication between brain cells. This is part of normal synapse function, which is how one nerve cell passes a message to the next.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some instances, though, a variant changes how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Some SLC6A17 gene variants that affect protein function change how the cell folds, stabilizes, or delivers the transporter to the right place in nerve cells. Milder missense variants may leave part of the transport activity intact, while more disruptive changes that create an early stop signal, shift the reading frame, or disrupt RNA splicing (an editing step before protein production) can greatly reduce activity or stop protein production altogether.
How variants are linked to conditions
Variants in the SLC6A17 gene do not yet have a broadly confirmed link to one specific health condition, though this can change as research develops. Information on how SLC6A17 gene variants are linked to conditions is still evolving, so anyone with a confirmed SLC6A17-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general summaries.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental influences are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC6A17 gene. For many living with a change in SLC6A17, risk appears to depend mainly on the specific genetic change rather than lifestyle or environmental factors, so personal guidance from a doctor or genetic counselor can be helpful.
Inheritance of SLC6A17 variants
SLC6A17-related conditions are inherited in an autosomal recessive pattern. In practical terms, how SLC6A17 variants are inherited usually means a child receives one nonworking copy of the SLC6A17 gene from each parent. Parents who carry one variant are typically unaffected carriers, and when both parents are carriers, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. Sons and daughters are affected at the same rate.
What does my SLC6A17 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for SLC6A17, though this understanding can change as research develops. If you have a specific SLC6A17 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SLC6A17 gene, doctors use genetic testing on a blood sample or saliva sample. SLC6A17 genetic testing reads the DNA code to see whether a variant is present and may be done as a single gene test, a panel, or exome sequencing. Results can show a known variant, no variant, or one with uncertain meaning.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the SLC6A17 gene in routine care. Testing decisions are usually based on symptoms, family history, and guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
Genetic results can be informative, but the amount they reveal depends on the condition and on the kind of variant involved. Factors like lifestyle, environment, age, and medical history also influence how the body functions over time. In some conditions, particularly those shaped by many genes, genetic information provides context instead of certainty and makes the most sense when considered with the rest of a person’s care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, moves, or responds to a drug, so the same treatment may work better for one person than another. This is common and can influence both how well a medicine helps and how likely someone is to notice side effects or sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the relationship between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the SLC6A17 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
In recent decades, awareness of the SLC6A17 gene’s role in brain research has grown. It was identified as scientists were cataloging members of the larger solute carrier family, a group of genes involved in moving small molecules in cells. Early studies gave it the name NTT4, and researchers first described it through laboratory work focused on nerve cells and brain tissue. From these first observations, research expanded steadily, linking SLC6A17 to the specialized chemical handling that supports communication between nerve cells. Although it has not entered public discussion in the way some higher profile genes have, it remains part of the steady progress that has shaped modern neurogenetics.